US Stock MarketDetailed Quotes

OMGA Omega Therapeutics

Watchlist

0.796
-0.001-0.08%

Close Nov 27 16:00 ET

0.820
+0.024+3.04%

Post 20:01 ET

44.06MMarket Cap-602P/E (TTM)

Omega Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

39.16%-14.02M

45.55%-12.67M

58.01%-11.81M

7.11%-91.51M

29.49%-17.09M

7.24%-23.04M

10.81%-23.27M

-20.39%-28.11M

-71.01%-98.52M

-51.90%-24.24M

Net income from continuing operations

26.09%-16.44M

45.08%-16.31M

20.37%-20.13M

5.13%-97.43M

34.43%-20.21M

13.76%-22.25M

-14.57%-29.69M

-25.37%-25.28M

-50.41%-102.7M

-47.82%-30.83M

Operating gains losses

----

---233K

---1K

--0

----

Depreciation and amortization

66.26%3.1M

-66.30%613K

38.94%1.82M

30.46%6.77M

35.44%1.78M

41.11%1.86M

36.97%1.82M

6.61%1.31M

274.19%5.19M

242.45%1.32M

Other non cash items

-52.17%11K

9.09%12K

-86.81%12K

81.25%145K

-41.18%20K

130.00%23K

-54.17%11K

658.33%91K

-24.53%80K

173.91%34K

Change In working capital

51.42%-2.41M

-37.30%1.8M

147.37%3.07M

5.22%-9.37M

-127.31%-806K

-91.53%-4.95M

173.32%2.86M

-2.02%-6.47M

-311.97%-9.88M

-11.99%2.95M

-Change in receivables

-74.38%206K

162.95%457K

3,383.92%4.98M

-1,422.93%-5.51M

-57,440.00%-5.73M

1,810.64%804K

-288.24%-726K

203.62%143K

-40.86%-362K

103.89%10K

-Change in prepaid assets

198.21%1.43M

516.28%530K

-12.62%616K

116.50%1.42M

1,001.30%2.08M

55.02%-1.46M

102.41%86K

145.11%705K

-224.72%-8.59M

-129.50%-231K

-Change in payables and accrued expense

14.79%-3.23M

-78.77%904K

74.29%-1.76M

-267.02%-7.05M

-115.21%-653K

-444.91%-3.79M

1,908.96%4.26M

-394.38%-6.86M

-43.15%4.22M

48.60%4.29M

-Change in other current assets

-95.64%19K

108.76%22K

122.22%22K

102.95%111K

103.26%25K

922.64%436K

-1,095.24%-251K

96.61%-99K

-2,512.18%-3.76M

-368.77%-766K

-Change in other current liabilities

12.39%-827K

76.63%-118K

-118.78%-792K

220.25%1.66M

1,078.59%3.47M

-168.95%-944K

-45.95%-505K

-9.37%-362K

-13,730.00%-1.38M

-2.31%-355K

Cash from discontinued investing activities

Operating cash flow

39.16%-14.02M

45.55%-12.67M

58.01%-11.81M

7.11%-91.51M

29.49%-17.09M

7.24%-23.04M

10.81%-23.27M

-20.39%-28.11M

-71.01%-98.52M

-51.90%-24.24M

Investing cash flow

Cash flow from continuing investing activities

97.79%-16K

-101.65%-396K

-79.75%4.47M

363.10%47.52M

-87.88%2.14M

-106.84%-724K

113.45%24.05M

138.30%22.05M

55.30%-18.06M

145.11%17.65M

Net PPE purchase and sale

97.79%-16K

61.70%-396K

---535K

-60.80%-2.22M

-57.88%-461K

-120.73%-724K

-70.07%-1.03M

--0

5.93%-1.38M

-46.00%-292K

Net investment purchase and sale

--0

-77.32%5M

398.17%49.73M

-85.50%2.6M

--0

111.23%25.08M

138.40%22.05M

57.16%-16.68M

146.09%17.94M

Cash from discontinued investing activities

Investing cash flow

97.79%-16K

-101.65%-396K

-79.75%4.47M

363.10%47.52M

-87.88%2.14M

-106.84%-724K

113.45%24.05M

138.30%22.05M

55.30%-18.06M

145.11%17.65M

Financing cash flow

Cash flow from continuing financing activities

-17,950.00%-1.44M

-608.22%-1.11M

-102.68%-1.07M

5,807.20%41.82M

177.30%1.63M

-300.00%-8K

525.71%219K

48,077.11%39.99M

-99.73%708K

-91.97%586K

Net issuance payments of debt

---1.45M

---1.11M

---1.09M

--1.62M

--0

----

Net common stock issuance

--0

--40M

--0

--40M

--0

Proceeds from stock option exercised by employees

-71.43%2K

--0

-79.63%22K

-31.07%488K

-99.66%2K

75.00%7K

960.00%371K

30.12%108K

158.39%708K

2,447.83%586K

Net other financing activities

----

---288K

--0

---15K

---152K

---121K

----

Cash from discontinued financing activities

Financing cash flow

-17,950.00%-1.44M

-608.22%-1.11M

-102.68%-1.07M

5,807.20%41.82M

177.30%1.63M

-300.00%-8K

525.71%219K

48,077.11%39.99M

-99.73%708K

-91.97%586K

Net cash flow

Beginning cash position

-56.37%46.19M

-42.44%60.37M

-3.06%68.78M

-62.02%70.96M

6.70%82.11M

16.10%105.88M

-1.04%104.88M

-62.02%70.96M

702.09%186.82M

-67.20%76.96M

Current changes in cash

34.89%-15.48M

-1,523.80%-14.18M

-124.79%-8.41M

98.13%-2.17M

-122.12%-13.33M

-66.88%-23.77M

106.73%996K

141.97%33.93M

-170.85%-115.87M

87.45%-6M

End cash Position

-62.59%30.72M

-56.37%46.19M

-42.44%60.37M

-3.06%68.78M

6.70%82.11M

16.10%105.88M

-1.04%104.88M

-62.02%70.96M

Free cash flow

40.95%-14.03M

46.24%-13.07M

56.10%-12.34M

5.52%-94.38M

25.80%-18.2M

5.57%-23.76M

8.97%-24.31M

-19.61%-28.11M

-69.10%-99.9M

-51.83%-24.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	39.16%-14.02M	45.55%-12.67M	58.01%-11.81M	7.11%-91.51M	29.49%-17.09M	7.24%-23.04M	10.81%-23.27M	-20.39%-28.11M	-71.01%-98.52M	-51.90%-24.24M
Net income from continuing operations	26.09%-16.44M	45.08%-16.31M	20.37%-20.13M	5.13%-97.43M	34.43%-20.21M	13.76%-22.25M	-14.57%-29.69M	-25.37%-25.28M	-50.41%-102.7M	-47.82%-30.83M
Operating gains losses	----	----	----	---233K	---1K	--0	----	----	----	----
Depreciation and amortization	66.26%3.1M	-66.30%613K	38.94%1.82M	30.46%6.77M	35.44%1.78M	41.11%1.86M	36.97%1.82M	6.61%1.31M	274.19%5.19M	242.45%1.32M
Other non cash items	-52.17%11K	9.09%12K	-86.81%12K	81.25%145K	-41.18%20K	130.00%23K	-54.17%11K	658.33%91K	-24.53%80K	173.91%34K
Change In working capital	51.42%-2.41M	-37.30%1.8M	147.37%3.07M	5.22%-9.37M	-127.31%-806K	-91.53%-4.95M	173.32%2.86M	-2.02%-6.47M	-311.97%-9.88M	-11.99%2.95M
-Change in receivables	-74.38%206K	162.95%457K	3,383.92%4.98M	-1,422.93%-5.51M	-57,440.00%-5.73M	1,810.64%804K	-288.24%-726K	203.62%143K	-40.86%-362K	103.89%10K
-Change in prepaid assets	198.21%1.43M	516.28%530K	-12.62%616K	116.50%1.42M	1,001.30%2.08M	55.02%-1.46M	102.41%86K	145.11%705K	-224.72%-8.59M	-129.50%-231K
-Change in payables and accrued expense	14.79%-3.23M	-78.77%904K	74.29%-1.76M	-267.02%-7.05M	-115.21%-653K	-444.91%-3.79M	1,908.96%4.26M	-394.38%-6.86M	-43.15%4.22M	48.60%4.29M
-Change in other current assets	-95.64%19K	108.76%22K	122.22%22K	102.95%111K	103.26%25K	922.64%436K	-1,095.24%-251K	96.61%-99K	-2,512.18%-3.76M	-368.77%-766K
-Change in other current liabilities	12.39%-827K	76.63%-118K	-118.78%-792K	220.25%1.66M	1,078.59%3.47M	-168.95%-944K	-45.95%-505K	-9.37%-362K	-13,730.00%-1.38M	-2.31%-355K
Cash from discontinued investing activities
Operating cash flow	39.16%-14.02M	45.55%-12.67M	58.01%-11.81M	7.11%-91.51M	29.49%-17.09M	7.24%-23.04M	10.81%-23.27M	-20.39%-28.11M	-71.01%-98.52M	-51.90%-24.24M
Investing cash flow
Cash flow from continuing investing activities	97.79%-16K	-101.65%-396K	-79.75%4.47M	363.10%47.52M	-87.88%2.14M	-106.84%-724K	113.45%24.05M	138.30%22.05M	55.30%-18.06M	145.11%17.65M
Net PPE purchase and sale	97.79%-16K	61.70%-396K	---535K	-60.80%-2.22M	-57.88%-461K	-120.73%-724K	-70.07%-1.03M	--0	5.93%-1.38M	-46.00%-292K
Net investment purchase and sale	--0	--0	-77.32%5M	398.17%49.73M	-85.50%2.6M	--0	111.23%25.08M	138.40%22.05M	57.16%-16.68M	146.09%17.94M
Cash from discontinued investing activities
Investing cash flow	97.79%-16K	-101.65%-396K	-79.75%4.47M	363.10%47.52M	-87.88%2.14M	-106.84%-724K	113.45%24.05M	138.30%22.05M	55.30%-18.06M	145.11%17.65M
Financing cash flow
Cash flow from continuing financing activities	-17,950.00%-1.44M	-608.22%-1.11M	-102.68%-1.07M	5,807.20%41.82M	177.30%1.63M	-300.00%-8K	525.71%219K	48,077.11%39.99M	-99.73%708K	-91.97%586K
Net issuance payments of debt	---1.45M	---1.11M	---1.09M	--1.62M	--1.62M	--0	--0	--0	--0	----
Net common stock issuance	--0	--0	--0	--40M	--0	--0	--0	--40M	--0	--0
Proceeds from stock option exercised by employees	-71.43%2K	--0	-79.63%22K	-31.07%488K	-99.66%2K	75.00%7K	960.00%371K	30.12%108K	158.39%708K	2,447.83%586K
Net other financing activities	----	----	----	---288K	--0	---15K	---152K	---121K	----	----
Cash from discontinued financing activities
Financing cash flow	-17,950.00%-1.44M	-608.22%-1.11M	-102.68%-1.07M	5,807.20%41.82M	177.30%1.63M	-300.00%-8K	525.71%219K	48,077.11%39.99M	-99.73%708K	-91.97%586K
Net cash flow
Beginning cash position	-56.37%46.19M	-42.44%60.37M	-3.06%68.78M	-62.02%70.96M	6.70%82.11M	16.10%105.88M	-1.04%104.88M	-62.02%70.96M	702.09%186.82M	-67.20%76.96M
Current changes in cash	34.89%-15.48M	-1,523.80%-14.18M	-124.79%-8.41M	98.13%-2.17M	-122.12%-13.33M	-66.88%-23.77M	106.73%996K	141.97%33.93M	-170.85%-115.87M	87.45%-6M
End cash Position	-62.59%30.72M	-56.37%46.19M	-42.44%60.37M	-3.06%68.78M	-3.06%68.78M	6.70%82.11M	16.10%105.88M	-1.04%104.88M	-62.02%70.96M	-62.02%70.96M
Free cash flow	40.95%-14.03M	46.24%-13.07M	56.10%-12.34M	5.52%-94.38M	25.80%-18.2M	5.57%-23.76M	8.97%-24.31M	-19.61%-28.11M	-69.10%-99.9M	-51.83%-24.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data